IBD development is associated with abnormal mucosal immunity, an impaired intestinal epithelial barrier, and intestinal dysbacteriosis in populations with genetic susceptibility (Xavier and Podolsky 2007), and FXR was shown to play a protective role in these aspects. Here, NR1H4 is linked to inflammatory bowel disease.